Thyroid medication is not commonly associated with breast enlargement, and it is not listed as a side effect on FDA prescribing labels for levothyroxine. However, there are indirect hormonal pathways through which thyroid treatment can influence breast tissue, and documented cases exist, particularly in men being treated for hyperthyroidism.
Why Thyroid Hormones Affect Breast Tissue
The connection between your thyroid and your breasts runs through a hormone called prolactin. The hypothalamus releases a signaling hormone called TRH, which tells your pituitary gland to produce both TSH (the hormone that drives your thyroid) and prolactin. Prolactin can directly cause breast tissue growth and lactation.
When your thyroid is underactive, your body ramps up TRH production to try to stimulate more thyroid hormone. That extra TRH also pushes prolactin levels higher as a side effect. Once you start taking thyroid medication and your hormone levels normalize, TRH drops back down, and prolactin typically follows. So for most people starting levothyroxine for hypothyroidism, treatment should actually reduce any prolactin-driven breast changes rather than cause them.
The exception is if your dose is too low or your levels fluctuate. Persistently elevated TRH from undertreated hypothyroidism can keep prolactin elevated, which some people notice as breast tenderness or fullness.
What the FDA Label Actually Lists
The official prescribing information for levothyroxine does not include breast enlargement, breast tenderness, or breast swelling among its recognized adverse reactions. The listed side effects are primarily symptoms of getting too much thyroid hormone: rapid heartbeat, weight loss, tremors, heat intolerance, hair loss, nervousness, diarrhea, and menstrual irregularities. The reproductive category mentions menstrual changes and impaired fertility but nothing specific to breast tissue.
This doesn’t mean breast changes never happen with thyroid treatment. It means they’re rare enough that they didn’t show up at a reportable frequency in clinical trials.
Breast Enlargement in Men With Thyroid Problems
The strongest documented link between thyroid conditions and breast growth is in men with hyperthyroidism, not hypothyroidism. Up to 40% of men with overactive thyroid conditions like Graves’ disease develop gynecomastia (noticeable breast tissue growth). This happens because excess thyroid hormone increases levels of a protein that binds testosterone, effectively lowering the amount of free testosterone available while estrogen levels rise.
Interestingly, some men develop breast enlargement not from the thyroid condition itself but from starting treatment for it. In one reported case, a 29-year-old man developed bilateral breast swelling just three days after beginning anti-thyroid medication, with the swelling gradually worsening before eventually resolving on its own as treatment continued. Other case reports describe breast tenderness and swelling appearing 14 to 103 days after starting anti-thyroid treatment or radioactive iodine therapy, typically resolving within two to four weeks.
These cases are thought to reflect rapid hormonal shifts as thyroid levels change. When hyperthyroidism is treated and hormone levels drop quickly, the body’s balance of estrogen and testosterone temporarily tilts in a way that stimulates breast tissue. This is generally temporary.
Estrogen, Thyroid Medication, and Binding Proteins
For women taking both thyroid medication and estrogen (whether as birth control or hormone replacement therapy), there’s another interaction worth understanding. Estrogen increases the liver’s production of a protein that binds thyroid hormone in the blood. This can make your thyroid medication less effective because more of the hormone gets locked up by the binding protein instead of staying active.
This doesn’t directly cause breast growth, but it can lead to undertreated hypothyroidism if your thyroid dose isn’t adjusted. Undertreated hypothyroidism means higher TRH and potentially higher prolactin, which circles back to the breast tissue pathway described earlier. If you start or stop estrogen therapy while taking levothyroxine, your thyroid levels may need rechecking.
What’s More Likely Causing the Change
If you’ve recently started thyroid medication and noticed breast changes, a few explanations are more probable than a direct drug effect. Hypothyroidism often causes weight loss resistance and fluid retention. As treatment kicks in, shifts in body composition and water balance can change how your body looks and feels, including in the chest area. Some people lose weight overall but notice redistribution rather than uniform change.
Hormonal rebalancing in the first weeks to months of treatment can also cause temporary breast tenderness or swelling as your body adjusts. Prolactin levels, estrogen metabolism, and menstrual regularity are all recalibrating during this period. These changes typically settle within a few months of reaching a stable dose.
If breast enlargement persists, is significant, or comes with nipple discharge, that’s worth investigating separately. Persistently elevated prolactin from causes unrelated to your thyroid, or other hormonal shifts, could be at play.